INDICATION

Aptensio XR® (methylphenidate HCl extended-release) is a central nervous system (CNS) stimulant prescription medicine used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in people 6 years of age and older.


Limitations of Use
Aptensio XR is not for use in children under 6 years of age because the safety and effectiveness have not been established.

IMPORTANT SAFETY INFORMATION

Aptensio XR is a federally controlled substance (CII) because it contains methylphenidate that can be a target for people who abuse prescription medicines or street drugs. Keep Aptensio XR in a safe place to protect it from theft. Never give your methylphenidate to anyone else, because it may cause death or harm to them. Selling or giving away Aptensio XR may harm others and is against the law. Tell your healthcare provider if you or your child have ever abused or been dependent on alcohol, prescription medicines, or street drugs.

Download and print these resources to take to your child's doctor appointments

Understanding ADHD Discussion Guide

If you suspect your child has ADHD, talk to his or her doctor and ask if medicine such as Aptensio XR® (methylphenidate HCI extended-release) can help. Use this guide before and during the doctor appointment to help make it informative and productive.

ADHD Treatment Discussion Guide

Every child with ADHD is different, and no one medication is right for every patient. Use this guide to help determine if you should consider other treatment options for your child.

ADHD Progress Diary

It is important to keep track of your child's symptoms throughout his or her treatment. Use this diary to help you keep a record of when your child takes medicine, his or her behavior that day, and any side effects he or she might experience.

IMPORTANT SAFETY INFORMATION

Aptensio XR is a federally controlled substance (CII) because it contains methylphenidate that can be a target for people who abuse prescription medicines or street drugs.